Shao L - Search Results

1

Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma.

Jiao XD, Ding LR, Zhang CT, Qin BD, Liu K, Jiang LP, Wang X, Lv LT, Ding H, Li DM, Yang H, Chen XQ, Zhu WY, Wu Y, Ling Y, He X, Liu J, Shao L, Wang HZ, Chen Y, Zheng JJ, Inui N, Zang YS. Jiao XD, et al. Among authors: shao l. Transl Lung Cancer Res. 2021 Jul;10(7):3236-3250. doi: 10.21037/tlcr-21-543. Transl Lung Cancer Res. 2021. PMID: 34430361 Free PMC article.

2

The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Li J, Xiang C, Wang Y, Zhou Y, Cao S, Ling X, Ye J, Zheng J, Shao L, Zhong H, Han Y. Li J, et al. Among authors: shao l. Ann Transl Med. 2021 May;9(9):779. doi: 10.21037/atm-20-6910. Ann Transl Med. 2021. PMID: 34268392 Free PMC article.

3

Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report.

Zhao Y, Chen Y, Huang H, Li X, Shao L, Ding H. Zhao Y, et al. Among authors: shao l. Onco Targets Ther. 2021 May 7;14:3063-3067. doi: 10.2147/OTT.S300556. eCollection 2021. Onco Targets Ther. 2021. PMID: 33994798 Free PMC article.

4

Non-small-cell lung cancer with epidermal growth factor receptor L861Q-L833F compound mutation benefits from both afatinib and osimertinib: A case report.

Zhang Y, Shen JQ, Shao L, Chen Y, Lei L, Wang JL. Zhang Y, et al. Among authors: shao l. World J Clin Cases. 2021 Sep 26;9(27):8220-8225. doi: 10.12998/wjcc.v9.i27.8220. World J Clin Cases. 2021. PMID: 34621884 Free PMC article.

5

Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer.

Wang Q, Wu L, Yu J, Li G, Zhang P, Wang H, Shao L, Liu J, Shen W. Wang Q, et al. Among authors: shao l. BMC Med Genomics. 2022 Mar 21;15(1):66. doi: 10.1186/s12920-022-01192-1. BMC Med Genomics. 2022. PMID: 35313869 Free PMC article.

6

Cell-free DNA from bronchoalveolar lavage fluid (BALF): a new liquid biopsy medium for identifying lung cancer.

Zeng D, Wang C, Mu C, Su M, Mao J, Huang J, Xu J, Shao L, Li B, Li H, Li B, Zhao J, Jiang J. Zeng D, et al. Among authors: shao l. Ann Transl Med. 2021 Jul;9(13):1080. doi: 10.21037/atm-21-2579. Ann Transl Med. 2021. PMID: 34422992 Free PMC article.

7

Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib.

Li J, Zhang B, Zhang Y, Xu F, Zhang Z, Shao L, Yan C, Ulivi P, Denis MG, Christopoulos P, Thomas de Montpréville V, Bernicker EH, van der Wekken AJ, Wang C, Yue D. Li J, et al. Among authors: shao l. Transl Lung Cancer Res. 2021 Mar;10(3):1525-1535. doi: 10.21037/tlcr-21-160. Transl Lung Cancer Res. 2021. PMID: 33889527 Free PMC article.

8

Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor.

He J, Ouyang W, Zhao W, Shao L, Li B, Liu B, Wang D, Han-Zhang H, Zhang Z, Shao L, Li W. He J, et al. Among authors: shao l. Ann Transl Med. 2021 Jan;9(2):129. doi: 10.21037/atm-20-7553. Ann Transl Med. 2021. PMID: 33569431 Free PMC article.

9

Comprehensive characterization and clinical impact of concomitant genomic alterations in EGFR-mutant NSCLCs treated with EGFR kinase inhibitors.

Cheng Y, Ma L, Liu Y, Zhu J, Xin Y, Liu X, Wang Y, Zhang T, Yang C, Wang S, Cui H, Zhang L, Dai J, Shao L, Lin J, Ye J, Liu H. Cheng Y, et al. Among authors: shao l. Lung Cancer. 2020 Jul;145:63-70. doi: 10.1016/j.lungcan.2020.04.004. Epub 2020 Apr 17. Lung Cancer. 2020. PMID: 32408134

10

Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).

Peng W, Cao L, Chen L, Lin G, Zhu B, Hu X, Lin Y, Zhang S, Jiang M, Wang J, Li J, Li C, Shao L, Du H, Hou T, Chen Z, Xiang J, Pu X, Li J, Xu F, Loong H, Wu L. Peng W, et al. Among authors: shao l. Oncologist. 2022 Mar 4;27(2):e116-e125. doi: 10.1093/oncolo/oyab044. Oncologist. 2022. PMID: 35641209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,212 results

Search Page